TECH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Bio-Techne Corp (TECH) is not a strong buy for a beginner investor with a long-term focus at this time. While there are some positive aspects like improved net income and EPS growth, the technical indicators, options sentiment, and insider/hedge fund selling trends suggest caution. The stock lacks significant positive momentum or catalysts to justify an immediate investment.
The MACD is negative and expanding (-0.843), indicating bearish momentum. RSI is neutral at 22.559, and moving averages are converging, showing no clear trend. The stock is trading near its support level (S1: 59.734), but overall technical indicators do not suggest a strong buy signal.
Analysts have raised price targets recently, with several firms maintaining Buy ratings.
Net income and EPS have shown YoY growth in the latest quarter.
Hedge funds and insiders are selling heavily, with hedge fund selling up 5004.01% and insider selling up 2911.08%.
Gross margin has declined YoY (-1.43%), and revenue has slightly dropped (-0.39%).
Lack of recent news or event-driven catalysts to drive the stock higher.
Weak technical indicators and bearish options sentiment.
In Q2 2026, revenue slightly decreased by -0.39% YoY to $295.88M. However, net income increased by 8.93% YoY to $38.00M, and EPS grew by 9.09% YoY to $0.24. Gross margin dropped to 65.29%, down -1.43% YoY, indicating some pressure on profitability.
Analysts have generally raised price targets, with targets now ranging from $62 to $80. Several firms maintain Buy ratings, citing potential growth in FY27 and beyond, but near-term growth is expected to remain flat. Some analysts suggest buying on pullbacks.
